Dose, Safety and Pathogenicity of SARS-CoV-2 (COVID-19) Omicron Virus (BA.5)

NCT06492564 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2 Infection

Interventions

BIOLOGICAL: SARS-CoV-2 omicron virus dose arm 1
BIOLOGICAL: SARS-CoV-2 omicron virus dose arm 2
BIOLOGICAL: SARS-CoV-2 omicron virus dose arm 3

Sponsor

Hvivo